The role of caveolin 1 in HIV infection and pathogenesis
A Mergia - Viruses, 2017 - mdpi.com
Caveolin 1 (Cav-1) is a major component of the caveolae structure and is expressed in a
variety of cell types including macrophages, which are susceptible to human …
variety of cell types including macrophages, which are susceptible to human …
[HTML][HTML] Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naive patients: a single-centre experience
Objectives Transmitted drug resistance (TDR) and HIV-1 genetic diversity may affect
treatment efficacy and clinical outcomes. Here we describe the circulating viral subtypes and …
treatment efficacy and clinical outcomes. Here we describe the circulating viral subtypes and …
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013–2016: impact on …
S Andreis, M Basso, R Scaggiante, M Cruciani… - Journal of global …, 2017 - Elsevier
Objectives To characterize the prevalence of transmitted drug resistance mutations (TDRMs)
by plasma analysis of 750 patients at the time of HIV diagnosis from January 1, 2013 to …
by plasma analysis of 750 patients at the time of HIV diagnosis from January 1, 2013 to …
Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): durability and virological response in a large Italian HIV drug resistance …
Background Dolutegravir (DTG) is a next-generation HIV integrase inhibitor (INI) with an
increased genetic barrier to resistance with respect to raltegravir (RAL) or elvitegravir (EVG) …
increased genetic barrier to resistance with respect to raltegravir (RAL) or elvitegravir (EVG) …
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection
Sir, Current guidelines recommend ART during primary HIV infection (PHI). 1–3 Before
initiating ART in a person with HIV-1 infection, genotypic antiretroviral (ARV) drug resistance …
initiating ART in a person with HIV-1 infection, genotypic antiretroviral (ARV) drug resistance …
Reduced probability of improving viro‐immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study
F Pennati, S Calza, A Di Biagio… - Immunity …, 2023 - Wiley Online Library
Introduction Young adults with vertical transmission (VT) of human immunodeficiency virus
(HIV) represent a fragile population. This study evaluates factors associated with viro …
(HIV) represent a fragile population. This study evaluates factors associated with viro …
Molecular epidemiology of HIV-1 virus in Puerto Rico: Novel cases of HIV-1 subtype C, D, and CRF-24BG
P López, O De Jesús, Y Yamamura… - AIDS Research and …, 2018 - liebertpub.com
HIV-1 subtype B virus is the most prevalent subtype in Puerto Rico (PR), accounting for
about 90% of infection in the island. Recently, other subtypes and circulating recombinant …
about 90% of infection in the island. Recently, other subtypes and circulating recombinant …
[PDF][PDF] Modelo de pronóstico para mejorar la efectividad en los medicamentos de los tratamientos antivirales en VIH Mayra Samara Ordóñez-Díaz1, Carmen Elisa …
MA Cárdenas - repository.urosario.edu.co
Objetivo: Mostrar mediante un modelo de pronóstico los sobrecostos que genera la falta de
adherencia y las mutaciones del virus de inmunodeficiencia humana, que confiere la …
adherencia y las mutaciones del virus de inmunodeficiencia humana, que confiere la …